New study reveals metformin's unexpected brain pathway and its wider impact

Findings show metformin acts on the brain at low doses, reshaping decades of understanding and pointing to more targeted approaches in diabetes treatment

If you or someone you know takes metformin, you might assume it lowers blood sugar primarily by acting on the liver. However, new findings suggest the story is far more complex, with the brain playing a crucial role in how the drug works.

 

A study titled “Low-dose metformin requires brain Rap1 for its antidiabetic effects”, published in the journal Science Advances, is now reshaping this understanding by identifying an unexpected mechanism centred in the brain.

 

What did the study find about metformin’s brain mechanism?

 

Traditionally, metformin was believed to lower blood sugar by acting on the liver and gut. However, researchers led by the Baylor College of Medicine have identified a previously hidden brain-based mechanism that plays a central role in how the drug works.

 

 

The study shows that the drug does not just act peripherally but also directly influences brain activity to regulate glucose levels.

 

“It’s been widely accepted that metformin lowers blood glucose primarily by reducing glucose output in the liver. Other studies have found that it acts through the gut,” said Makoto Fukuda, a pathophysiologist at Baylor.

 

“We looked into the brain as it is widely recognised as a key regulator of whole-body glucose metabolism. We investigated whether and how the brain contributes to the anti-diabetic effects of metformin,” he added.

 

The researchers focused on a small protein called Rap1, located in the ventromedial hypothalamus (VMH), a region that helps regulate energy balance and blood sugar. They found:

 

• Metformin suppresses Rap1 activity in the brain
• This suppression is essential for lowering blood glucose
• The drug activates specific nerve cells known as SF1 neurons
• These neurons help regulate whole-body glucose metabolism

 

In simple terms, instead of only working through organs like the liver, metformin also taps into the brain’s control centre for energy regulation. 

 

Why this discovery matters for diabetes treatment

 

“These findings open the door to developing new diabetes treatments that directly target this pathway in the brain,” said Fukuda.

 

Key implications include:

 

• More precise treatments: Therapies could be developed to directly target the brain pathway
• Lower drug doses: The brain responds to smaller amounts of metformin than other organs
• Improved effectiveness: Understanding this pathway may explain why metformin works well for many patients

 

Importantly, most current diabetes drugs do not target the brain, making this finding particularly significant.

 

Beyond blood sugar: What other effects could metformin have?

 

Scientists believe this brain pathway may also help explain some of metformin’s broader effects, which have long puzzled researchers. There is growing evidence that metformin:

 

• May influence appetite and weight regulation
• Could play a role in slowing brain ageing
• Has potential links to cognitive and neurological health 

Researchers are now exploring whether the same Rap1 pathway could be responsible for these additional benefits.

 

This study highlights that even well-established drugs can hold hidden mechanisms that only modern research tools can uncover. 

 

What comes next in metformin research?

 

While the findings are promising, researchers caution that more work is needed, particularly in human studies. The current evidence strongly supports a brain-based mechanism, but scientists aim to further explore how this pathway can be safely and effectively targeted in clinical settings.

 

Future research will likely focus on:

 

• Confirming these effects in humans
• Developing brain-targeted diabetes therapies
• Exploring links to neurological and metabolic disorders

 

For more health updates, follow #HealthwithBS

This report is for informational purposes only and is not a substitute for professional medical advice.